Joshua Pinto, Chief Financial Officer at Neumora Therapeutics, Inc. (NMRA), sold 31,386 shares at $11.39 ($357K) on 2024-08-27, disclosed to the SEC on 2024-08-27.
Scheduled sale ($357k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.39 | 15,693 | $179K | 50.0% |
| 2 | $11.39 | 15,693 | $179K | 50.0% |
| Total | $11.39 avg | 31,386 | $357K | 100% |
| Filing → |
| NMRA | SELL | 2024-08-26 | $2.0M | — | Filing → |